Anna Lena Lopez

Summary

Affiliation: International Vaccine Institute

Publications

  1. ncbi Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults
    Dang Duc Anh
    National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
    Vaccine 25:1149-55. 2007
  2. pmc A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India
    Dilip Mahalanabis
    Society for Applied Studies, Kolkata, India
    PLoS ONE 3:e2323. 2008
  3. ncbi Cholera vaccines for the developing world
    Anna Lena Lopez
    International Vaccine Institute, Seoul, Korea
    Hum Vaccin 4:165-9. 2008
  4. doi 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial
    Sujit K Bhattacharya
    National Institute of Cholera and Enteric Diseases, Kolkata, India Indian Council of Medical Research, New Delhi, India
    Lancet Infect Dis 13:1050-6. 2013
  5. pmc Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial
    Dipika Sur
    National Institute of Cholera and Enteric Diseases, Kolkata, India
    PLoS Negl Trop Dis 5:e1289. 2011
  6. doi Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India
    Mohammad Ali
    International Vaccine Institute, Seoul, Republic of Korea
    Clin Infect Dis 56:1123-31. 2013
  7. doi Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
    Dipika Sur
    National Institute of Cholera and Enteric Diseases, Kolkata, India
    Lancet 374:1694-702. 2009
  8. doi Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial
    Suman Kanungo
    National Institute of Cholera and Enteric Diseases, Kolkata, India
    Vaccine 27:6887-93. 2009
  9. pmc Risk map of cholera infection for vaccine deployment: the eastern Kolkata case
    Young Ae You
    International Vaccine Institute, Seoul, Republic of Korea
    PLoS ONE 8:e71173. 2013
  10. pmc Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysis
    Mohammad Ali
    International Vaccine Institute, Seoul, Korea
    J Health Popul Nutr 28:450-7. 2010

Collaborators

Detail Information

Publications19

  1. ncbi Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults
    Dang Duc Anh
    National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
    Vaccine 25:1149-55. 2007
    ..We found that this reformulated oral killed whole-cell cholera vaccine was safe, well tolerated and highly immunogenic...
  2. pmc A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India
    Dilip Mahalanabis
    Society for Applied Studies, Kolkata, India
    PLoS ONE 3:e2323. 2008
    ..This vaccine was reformulated to meet WHO requirements. We assessed the safety and immunogenicity of the reformulated bivalent (Vibrio cholerae 01 and 0139) killed whole cell oral vaccine in a cholera endemic area in Kolkata, India...
  3. ncbi Cholera vaccines for the developing world
    Anna Lena Lopez
    International Vaccine Institute, Seoul, Korea
    Hum Vaccin 4:165-9. 2008
    ..We review oral cholera vaccines that are currently available and in the pipeline including the need for policies that will ensure more extensive usage of these vaccines...
  4. doi 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial
    Sujit K Bhattacharya
    National Institute of Cholera and Enteric Diseases, Kolkata, India Indian Council of Medical Research, New Delhi, India
    Lancet Infect Dis 13:1050-6. 2013
    ..We aimed to assess protective efficacy up to 5 years in a slum area of Kolkata, India...
  5. pmc Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial
    Dipika Sur
    National Institute of Cholera and Enteric Diseases, Kolkata, India
    PLoS Negl Trop Dis 5:e1289. 2011
    ..Killed oral cholera vaccines (OCVs) have been licensed for use in developing countries, but protection conferred by licensed OCVs beyond two years of follow-up has not been demonstrated in randomized, clinical trials...
  6. doi Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India
    Mohammad Ali
    International Vaccine Institute, Seoul, Republic of Korea
    Clin Infect Dis 56:1123-31. 2013
    ..We evaluated the herd protection conferred by an oral cholera vaccine using 2 approaches: cluster design and geographic information system (GIS) design...
  7. doi Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
    Dipika Sur
    National Institute of Cholera and Enteric Diseases, Kolkata, India
    Lancet 374:1694-702. 2009
    ..To expand the use of this vaccine, it was modified to comply with WHO standards. We assessed the efficacy and safety of this modified vaccine in a population with endemic cholera...
  8. doi Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial
    Suman Kanungo
    National Institute of Cholera and Enteric Diseases, Kolkata, India
    Vaccine 27:6887-93. 2009
    ..Responses to V. cholerae O139 were less pronounced but followed a similar pattern. We demonstrate that in a cholera-endemic area, the vaccine elicited vibriocidal responses after a single-dose of the vaccine...
  9. pmc Risk map of cholera infection for vaccine deployment: the eastern Kolkata case
    Young Ae You
    International Vaccine Institute, Seoul, Republic of Korea
    PLoS ONE 8:e71173. 2013
    ..Here we investigate socio-environmental characteristics between high and low risk areas as well as the potential impact of vaccination on the spatial occurrence of the disease...
  10. pmc Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysis
    Mohammad Ali
    International Vaccine Institute, Seoul, Korea
    J Health Popul Nutr 28:450-7. 2010
    ..The results illustrated that participation in the trial was mostly influenced by various individual and community-level factors, which need to be addressed for a successful vaccination campaign...
  11. pmc The global burden of cholera
    Mohammad Ali
    International Vaccine Institute, SNU Research Park, Seoul, Republic of Korea
    Bull World Health Organ 90:209-218A. 2012
    ..To estimate the global burden of cholera using population-based incidence data and reports...
  12. pmc The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa
    Jacqueline L Deen
    International Vaccine Institute, Seoul, Korea
    PLoS Negl Trop Dis 2:e173. 2008
    ..Cholera remains an important public health problem. Yet there are few reliable population-based estimates of laboratory-confirmed cholera incidence in endemic areas around the world...
  13. pmc Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy
    Ramadhan Hashim
    International Vaccine Institute, Seoul, Korea
    PLoS Negl Trop Dis 6:e1743. 2012
    ..Balancing this concern is the known higher risk of cholera and of complications of pregnancy should cholera occur in these women, as well as the lack of expected adverse events from a killed oral bacterial vaccine...
  14. pmc Use of verbal autopsy to determine mortality patterns in an urban slum in Kolkata, India
    Suman Kanungo
    National Institute of Cholera and Enteric Diseases, Kolkata, India
    Bull World Health Organ 88:667-74. 2010
    ..To define mortality patterns in an urban slum in Kolkata, India, in the context of a cholera and typhoid fever project...
  15. pmc Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India
    Suman Kanungo
    Department of Epidemiology, National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India
    PLoS ONE 9:e96499. 2014
    ..However, the ascertainment of correlates of immunity conferred by any vaccine is a difficult task...
  16. pmc Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008
    Binh Minh Nguyen
    National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
    J Clin Microbiol 47:1568-71. 2009
    ....
  17. pmc Tetracycline-Resistant Vibrio cholerae O1, Kolkata, India
    Koel Bhattacharya
    National Institute of Cholera and Enteric Diseases, Kolkata, India K Bhattacharya, S Kanungo, D Sur, B L Sarkar, B Manna, M Bhattacharya, S Nandy, S K Niyogi and International Vaccine Institute, Seoul, South Korea A L Lopez
    Emerg Infect Dis 17:568-9. 2011
    ..We report the emergence of tetracycline-resistant V. cholerae O1 in a well-defined population in Kolkata, India, during 2007-2009...
  18. pmc Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of Tanzania
    Mohammad Ali
    International Vaccine Institute, Kwanak PO Box 14, Seoul, 151 600, Republic of Korea
    Bull World Health Organ 88:556-9. 2010
    ..Field trials require extensive data preparation and complex logistics. The use of personal digital assistants (PDAs) can bypass many of the traditional steps that are necessary in a paper-based data entry system...
  19. ncbi Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission
    Mohammad Ali
    International Vaccine Institute, Seoul, Korea
    Pediatr Infect Dis J 27:33-7. 2008
    ..We investigated whether mass immunization of older children and adults can confer herd protection to children too young to be vaccinated...